Novartis
NVS
NVS
1,140 hedge funds and large institutions have $16.9B invested in Novartis in 2022 Q2 according to their latest regulatory filings, with 89 funds opening new positions, 348 increasing their positions, 446 reducing their positions, and 75 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
1,140
Holders Change
+4
Holders Change %
+0.35%
% of All Funds
19.28%
Holding in Top 10
8
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+33.33%
% of All Funds
0.14%
New
89
Increased
348
Reduced
446
Closed
75
Calls
$322M
Puts
$215M
Net Calls
+$107M
Net Calls Change
-$11.7M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$265M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$142M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$40M |
| 4 |
JPMorgan Chase & Co
New York
|
+$37.6M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$36.5M |
Top Sellers
| 1 |
Dodge & Cox
San Francisco,
California
|
-$447M |
| 2 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$154M |
| 3 |
Lazard Asset Management
New York
|
-$93.6M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$64.8M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$48.2M |
